On Tuesday, Amneal Pharmaceuticals Inc (NASDAQ: AMRX) was 2.14% up from the session before settling in for the closing price of $7.96. A 52-week range for AMRX has been $6.50 – $9.48.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 32.70%. When this article was written, the company’s average yearly earnings per share was at 28.45%. With a float of $143.72 million, this company’s outstanding shares have now reached $313.42 million.
Let’s determine the extent of company efficiency that accounts for 8300 employees. In terms of profitability, gross margin is 37.67%, operating margin of 13.19%, and the pretax margin is 3.13%.
Amneal Pharmaceuticals Inc (AMRX) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Amneal Pharmaceuticals Inc stocks. The insider ownership of Amneal Pharmaceuticals Inc is 54.15%, while institutional ownership is 39.25%. The most recent insider transaction that took place on Jun 16 ’25, was worth 761,146. In this transaction Director of this company sold 94,906 shares at a rate of $8.02, taking the stock ownership to the 1,609,144 shares. Before that another transaction happened on Jun 10 ’25, when Company’s Director sold 56,426 for $8.02, making the entire transaction worth $452,537. This insider now owns 1,704,050 shares in total.
Amneal Pharmaceuticals Inc (AMRX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 28.45% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 22.77% during the next five years compared to 32.70% growth over the previous five years of trading.
Amneal Pharmaceuticals Inc (NASDAQ: AMRX) Trading Performance Indicators
You can see what Amneal Pharmaceuticals Inc (AMRX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.88. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.89. Likewise, its price to free cash flow for the trailing twelve months is 9.41.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.01, a number that is poised to hit 0.16 in the next quarter and is forecasted to reach 0.89 in one year’s time.
Technical Analysis of Amneal Pharmaceuticals Inc (AMRX)
Looking closely at Amneal Pharmaceuticals Inc (NASDAQ: AMRX), its last 5-days average volume was 1.75 million, which is a jump from its year-to-date volume of 1.68 million. As of the previous 9 days, the stock’s Stochastic %D was 44.12%.
During the past 100 days, Amneal Pharmaceuticals Inc’s (AMRX) raw stochastic average was set at 59.92%, which indicates a significant increase from 51.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.21 in the past 14 days, which was lower than the 0.27 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.92, while its 200-day Moving Average is $8.07.
